$COSM Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit globenewswire.com/news-relea…
$COSM “These orders reflect the demand for Cana's contract manufacturing capabilities and the strength of our vertically integrated platform. By deepening our…” globenewswire.com/news-relea…
$COSM Cosmos Health Reports Annualized Sales Exceeding $1.5M for Its C-Scrub and C-Sept Antiseptic Brands in the UK and Greece; Plans EU Expansion Targeting $7.4M in Revenue and $5.3M in Gross Profit stockverse.com/news/cosmos-h…